Back
The Clinical Trials Ward. Established with funding from the Government of Uganda through the Ministry of Science, Technology, and Innovation
A trial participant receives COVID-19 Convalescent Plasma during the trial
Processed COVID-19 Convalescent Plasma used for the COVID-19 Convalescent Plasma trial
Negative 20 freezers donated by World Health Organisation
Vaccine cold chain facility with power back. The facility was set up with support from World Health Organisation
Negative 80 freezers for biobanking
The Clinical Trials Ward. Established with funding from the Government of Uganda through the Ministry of Science, Technology, and Innovation
The VERC clinical trial team attending to a participant on one of the trials
HE Yoweri Kaguta Museveni launching the UBV-01 N trial. The trial assessed efficacy and safety of a locally manufactured therapeutic product (UBV-01N)
Makerere University leadership during the launch of a COVID-19 research study
Dr Yonas Tegegn Woldemariam, the WHO-WR (Uganda) during the receipt of the Ebola trial vaccines
World Health Organisation, Ministry of Health, Tokomeza Ebola Vaccine trial Investigators receive the Ebola candidate vaccines for the trial
The Vaccine House. The building has office space and also houses the cold chain facility


The Vaccine and Epidemics Research Centre (VERC) started out as the COVID-19 research group in March 2020 as a response to the COVID-19 pandemic. The group later got involved in several other pandemic/epidemic responsive research which necessitated the transition into a Vaccine and Epidemics Research Centre.   VERC is based at Makerere University Lung Institute within Makerere University College of Health Sciences. The Centre brings together a multidisciplinary team of scientists and partner institutions all working together to develop and/or implement biomedical and socio-behavioral innovations for responding to new and emerging disease threats.

Mission

Epidemic driven research to improve the health of populations.

Vision

To provide high-quality scientific evidence for informed decision-making, and development of robust strategies for epidemic control and improved public health of African populations

Values

  1. Integrity
  2. Collaboration
  3. Adaptability
  4. Agility